We are committed to convening and supporting partners advancing patient-centered, innovative, evidence-based solutions addressing this public health challenge.
Collaboration is key to ending the opioid crisis. Now more than ever, it is critical for us to think creatively, test new approaches, remove silos, and enhance and expand activities proven to prevent and reduce opioid use disorder.
We welcome the opportunity to explore partnerships and collaborate with all who are dedicated to furthering our goal of accelerating solutions to end this public health emergency.
FORE is a national grantmaking organization focused on ending the nation’s opioid crisis. We are deeply committed to enhancing access to care for all Americans experiencing an opioid use disorder and enabling communities to invest in prevention.
The cost of inaction is simply too high. Over 180 Americans die every day from opioid overdoses. Families are facing hardships while the resources of clinicians, first responders, and others are stretched thin. The stigma of addiction and shortage of evidence-based prevention and treatment options have left many without the help they need.
Our funding priorities are shaped by convening leaders in addiction medicine, pain management, public health, health policy, and health care delivery. I am grateful to those who have given their time to inform our efforts to help everyone affected by this public health emergency.
No single solution will solve this crisis. For this reason, we support patient-centered efforts that aim to achieve the following:
- Educate healthcare and other professionals about prevention and evidence-based treatment
- Develop sustainable prevention, treatment, and recovery models, as well as payment and provider approaches
- Inform State and Federal policies to ensure access to care
- Raise public awareness of effective strategies for curtailing the crisis
We look forward to continue developing a strong network of grantees, partners, and collaborators.
Karen A. Scott
Our leadership and staff are renowned experts with the vision and passion to drive our mission forward.
Hoover Adger, Jr., MD, MPH, MBA Professor of Pediatrics & Director of Adolescent Medicine at Johns Hopkins University School of Medicine; Past President of the Association for Medical Education and Research in Substance Abuse (AMERSA)
Dr. Adger is a professor of pediatrics at the Johns Hopkins University School of Medicine. He was the previous director of Adolescent Medicine in the Division of General Pediatrics and Adolescent Medicine, and now is a senior faculty member in the newly created Division of Adolescent & Young Adult Medicine. Dr. Adger is the director of the Substance Use Assessment/Intervention Team at The Johns Hopkins Hospital Adolescent Program. He is a past Deputy Director of the White House Office of National Drug Control Policy.
Keith Humphreys, PhD Esther Ting Memorial Professor of Psychiatry at Stanford University
Dr. Humphreys is the Esther Ting Memorial Professor in the Department of Psychiatry and Behavioral Sciences at Stanford University. He is also a Senior Research Career Scientist at the VA Health Services Research Center in Palo Alto, CA, and an Honorary Professor of Psychiatry at the Institute of Psychiatry, King’s College, London. His research addresses the prevention and treatment of addictive disorders, the formation of public policy, and the extent to which subjects in medical research differ from patients seen in everyday clinical practice.
Erin Krebs, MD, MPH Chief of General Internal Medicine at Minneapolis VA Health Care System; Core Investigator at Minneapolis VA Center for Care Delivery and Outcomes Research; Professor of Medicine at University of Minnesota
Dr. Krebs is a health services researcher, chief of general internal medicine at the Minneapolis VA Health Care System, and professor at the University of Minnesota Medical School. Her professional goal is to improve the management of chronic pain in primary care. She conducts research focused on chronic pain, benefits and harms of opioid analgesics, and care of patients prescribed long-term opioids.
Cortney Lovell Partner & Co-Founder of Our Wellness Collective
Ms. Lovell is an innovative recovery leader who has spent the past decade growing wellness and recovery-focused initiatives across local, state, federal, and international levels. A recovery professional and coach, Ms. Lovell is the Co-Founder and Partner of Our Wellness Collective, RecoveryTraining.Online, and is the Cross-Systems Director of Families Together in New York State.
Paul N. Samuels, JD Director and President of Legal Action Center
Mr. Samuels is Director and President of the Legal Action Center. For more than four decades, Mr. Samuels has worked on a wide range of substance use disorder/mental health and criminal justice legal and policy issues at the federal, state, and local levels, including developing creative strategies to increase public and private financing for treatment and improve the quality of treatment, and to move the criminal legal system to a primary focus on diverting people to needed health care rather than punishment and incarceration. He works with government agencies, service providers, national organizations, and the recovery community and other directly impacted people to implement those strategies and educate the public and policymakers.
José Szapocznik, PhD Chair Emeritus of the Department of Public Health Sciences & Director of the Center for Family Studies at University of Miami Miller School of Medicine
Dr. Szapocznik is Professor of Public Health Sciences, Psychology, Architecture, and Educational & Psychological Studies at the University of Miami. He is founding director for the NIDA-funded National Drug Abuse Treatment Clinical Trials Network’s Florida Node Alliance, one of fifteen drug abuse treatment research centers in the Network. He was also the founding director of the NCATS/NIMHD-funded Miami Clinical and Translational Science Institute. He has been a NIDA-funded researcher since 1978, having received over $125 Million from the NIH. He has made pioneering contributions to drug prevention and treatment research with Hispanic adolescents and their families.
Stephen Taylor, MD, MPH, FASAM Medical Director of the Player Assistance and Anti-Drug Program of the National Basketball Association/National Basketball Players Association
Dr. Taylor is a psychiatrist who focuses on helping adolescents and adults avoid or overcome addiction disorders and cooccurring psychiatric disorders. For 14 years, he has served as medical director of the Player Assistance and Anti-Drug Program of the National Basketball Association/National Basketball Players Association. He also serves as the chief medical officer of the behavioral health division at Pathway Healthcare, which operates 13 mental health and addiction treatment centers across Alabama, Mississippi, Tennessee, and Texas. In addition, he is a member of the American Society of Addiction Medicine’s (ASAM) board of directors and chairs ASAM’s delegation to the American Medicine Association’s House of Delegates.
Mishka Terplan, MD, MPH, FACOG, DFASAM Senior Physician Research Scientist at Friends Research Institute
Dr. Terplan is board certified in both obstetrics and gynecology and in addiction medicine. His primary clinical, research and advocacy interests lie along the intersections of reproductive and behavioral health. He is Associate Medical Director at Friends Research Institute, Deputy Chief Clinical Officer at the Department of Behavioral Health, District of Columbia, and adjunct faculty at the University of California, San Francisco where he is a Substance Use Warmline clinician for the National Clinician Consultation Center.
Andrea Barthwell, MD, DFASAM, Board Chair Medical Director at Encounter Medical Group; Founder and CEO of Two Dreams Chicago
Dr. Barthwell, past president of the American Society of Addition Medicine (ASAM), is Founder of Encounter Medical Group, P.C., and Director at Two Dreams, a comprehensive alcoholism and addiction treatment system. From 2003-2004, she served as Deputy Director for Demand Reduction in the White House Office of National Drug Control Policy (ONDCP).
Adrienne M. Brown, MSW, LMSW
Ms. Brown is a dedicated social services professional with over 30 years of experience in providing high quality support services to diverse communities. She served as a senior administrator at Alcoholics Anonymous World Services for 17 years. Ms. Brown is a certified recovery peer advocate.
H. Westley Clark, MD, JD, MPH Dean’s Executive Professor of Public Health at Santa Clara University
Dr. Clark is the former Director of the Center for Substance Abuse Treatment at SAMHSA. He contributed to the 2016 Surgeon General’s Report on Alcohol, Drugs, and Health as a Section Editor for Treatment. Dr. Clark is a Distinguished Fellow of the American Society of Addiction Medicine and is a member of the National Advisory Council of NIDA. He is ABAM certified in Addiction Medicine, is licensed to practice medicine in California, Maryland, Massachusetts, and Michigan, and is also a member of the Washington, DC, Bar.
Lori A. Schechter, JD Executive Vice President, Chief Legal Officer & General Counsel at McKesson Corporation
Ms. Schechter is Executive Vice President, Chief Legal Officer & General Counsel for the McKesson Corporation. Previously, she was a litigation partner at Morrison & Foerster where she represented clients in complex litigation and investigations. She was named by the National Law Journal as one of the “Top 50 Female Litigators in the Country.” She currently serves on the Board of the National Center for Youth Law, and previously served on the Board of Legal Aid at Work.
Richard S. Schottenfeld, MD Professor and Chair of the Department of Psychiatry and Behavioral Sciences at Howard University College of Medicine
Dr. Schottenfeld is a leading clinical researcher, educator, and developer of drug use clinical programs and services. He has authored more than 125 peer-reviewed publications and has played a key role in the development and expansion of primary care-based treatments for OUD. He is currently the PI of a NIDA-funded Clinical Trials Network study investigating innovative strategies for addressing stigma and expanding treatment and recovery services in urban, poor, and minority communities.
Peter Slone Senior Vice President of Corporate Public Affairs at McKesson Corporation
Mr. Slone has been Senior Vice President of Corporate Public Affairs at the McKesson Corporation since June 2015. Previously, he was Vice President of Global Government Affairs at Medtronic plc, where he served for over 13 years.
Adam Usdan President of Trellus Management Corporation LLC
Mr. Usdan has been in the investment advisory industry for over 32 years, founding Trellus Partners in 1994. Mr. Usdan began his investment career in 1987 at Odyssey Partners, where he was responsible for managing long/short U.S. equity. He currently serves on the Boards of Griffin Mining, Wesleyan University, The Jewish Board for Children and Family Services, and The Jonas Center for Nursing and Veterans Healthcare.
FORE was started with a gift from the McKesson Corporation.